Michael Poyurovsky
Research Unit
Tirat Carmel Mental Health Center
Rappaport Faculty of Medicine
Israel Institute of Technology - Technion
Israel
Name/email consistency: high
- Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms. Poyurovsky, M., Glick, I., Koran, L.M. J. Psychopharmacol. (Oxford) (2010)
- Effect of the selective norepinephrine reuptake inhibitor reboxetine on cognitive dysfunction in schizophrenia patients: an add-on, double-blind placebo-controlled study. Poyurovsky, M., Faragian, S., Fuchs, C., Pashinian, A. Isr. J. Psychiatry. Relat. Sci (2009)
- Clinical characteristics of schizotypal-related obsessive-compulsive disorder. Poyurovsky, M., Faragian, S., Pashinian, A., Heidrach, L., Fuchs, C., Weizman, R., Koran, L. Psychiatry. Res (2008)
- Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder. Poyurovsky, M., Faragian, S., Shabeta, A., Kosov, A. Psychiatry. Res (2008)
- Awareness of illness and insight into obsessive-compulsive symptoms in schizophrenia patients with obsessive-compulsive disorder. Poyurovsky, M., Faragian, S., Kleinman-Balush, V., Pashinian, A., Kurs, R., Fuchs, C. J. Nerv. Ment. Dis. (2007)
- Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study. Poyurovsky, M., Fuchs, C., Pashinian, A., Levi, A., Faragian, S., Maayan, R., Gil-Ad, I. Psychopharmacology (Berl.) (2007)
- Neurological soft signs in schizophrenia patients with obsessive-compulsive disorder. Poyurovsky, M., Faragian, S., Pashinian, A., Levi, A., Viosburd, A., Stryjer, R., Weizman, R., Fuchs, C., Weizman, A. J. Neuropsychiatry. Clin. Neurosci (2007)
- Preferential aggregation of obsessive-compulsive spectrum disorders in schizophrenia patients with obsessive-compulsive disorder. Poyurovsky, M., Fuchs, C., Faragian, S., Kriss, V., Weisman, G., Pashinian, A., Weizman, R., Weizman, A. Can. J. Psychiatry (2006)
- Obsessive-compulsive disorder in elderly schizophrenia patients. Poyurovsky, M., Bergman, J., Weizman, R. J. Psychiatr. Res (2006)
- Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial. Poyurovsky, M., Pashinian, A., Weizman, R., Fuchs, C., Weizman, A. Biol. Psychiatry (2006)
- Familial aggregation of schizophrenia-spectrum disorders and obsessive-compulsive associated disorders in schizophrenia probands with and without OCD. Poyurovsky, M., Kriss, V., Weisman, G., Faragian, S., Schneidman, M., Fuchs, C., Weizman, A., Weizman, R. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2005)
- The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients. Poyurovsky, M., Pashinian, A., Levi, A., Weizman, R., Weizman, A. Int. Clin. Psychopharmacol (2005)
- Obsessive-compulsive disorder (OCD) with schizotypy vs. schizophrenia with OCD: diagnostic dilemmas and therapeutic implications. Poyurovsky, M., Koran, L.M. J. Psychiatr. Res (2005)
- Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. Poyurovsky, M., Weizman, A., Weizman, R. CNS. Drugs (2004)
